Resources and Information
»Clinical Guidelines STAGING
Sep 24 2006
Should We Treat All Ocular Hypertensives?
Excerpted from a presentation by Dr. Anthony Litwak at an NGS program, December 2005. Click below to listen.
<br/>
<br/>
<br/>
read more
»In Your Office STAGING
Sep 11 2006
Expanded Coverage of Glaucoma Screening Services
Medicare coverage of glaucoma screening examinations modified in 2006.
read more: Full Members Only
»Clinical Guidelines STAGING
Sep 11 2006
The Paradox of IOP
Excerpted from a presentation by Dr. Jim Thimons at the National Glaucoma Symposium: East, Cape Cod, MA, August 2006.
read more
»Glaucoma Watch STAGING
Jul 30 2006
Introduction to the National Glaucoma Society
"The excellence in glaucoma care starts in your chair, every day." Listen to Dr. Jim Thimons talk about the National Glaucoma Society.
read more
»Industry News STAGING
Jun 26 2006
New FDA Approval for Lumigan
The FDA has approved Allergan's glaucoma medication, Lumigan for first-line treatment for elevated intraocular pressure associated with ocular hypertension or open angle glaucoma.
read more
»Clinical Guidelines STAGING
Jun 21 2006
More CCT
An interesting retrospective study in the Journal of Glaucoma, April 2006, addresses the importance of CCT as a predictor of localized RNLF defects at initial evaluation for NTG.
read more
»In Your Office STAGING
Jun 21 2006
BCBS Coverage of SCODI Services
Starting July 1, Blue Cross Blue Shield of Massachusetts will extend coverage to patients for Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) services, CPT 92135, provided by Doctors of Optometry.
read more
»Clinical Guidelines STAGING
Apr 12 2006
The Role of CCT in Glaucoma Patients
The Ocular Hypertension Study (OHTS) was the first multi-center trial to demonstrate the relationship between CCT and risk of progression to glaucoma in Ocular Hypertensive patients. While this information has established a new standard in the care for our patients, it has also opened discussion regarding the usefulness of this information in areas other than Ocular Hypertensives.
read more
